Unknown

Dataset Information

Targeted therapy for immune mediated skin diseases. What should a dermatologist know?


ABSTRACT:

Background

Molecularly targeted therapies, such as monoclonal antibodies (mAbs) and Janus Kinase inhibitors (JAKis), have emerged as essential tools in the treatment of dermatological diseases. These therapies modulate the immune system through specific signaling pathways, providing effective alternatives to traditional systemic immunosuppressive agents. This review aims to provide an updated summary of targeted immune therapies for inflammatory skin diseases, considering their pathophysiology, efficacy, dosage, and safety profiles.

Methods

The review followed the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines. A systematic search was conducted on PubMed over the past 10 years, focusing on randomized clinical trials, case reports, and

SUBMITTER: Lopez E 

PROVIDER: S-EPMC11221168 | biostudies-literature | 2024 Jul-Aug

REPOSITORIES: biostudies-literature